(Q36192991)

12 August 2017

1 reference

title

Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon? (English)

1 reference

12 August 2017

1 reference

Bharathi Raju

1

1 reference

12 August 2017

Philip E Cryer

series ordinal

2

1 reference

12 August 2017

publication date

1 August 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

12 August 2017

published in

1 reference

12 August 2017

volume

289

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

E181-6

1 reference

Hypoglycemia, defective islet glucagon secretion, but normal islet mass in mice with a disruption of the gastrin gene

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Glucose counterregulation: prevention and correction of hypoglycemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Glucagon and regulation of glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Regulation and Counterregulation of Lipolysisin Vivo: Different Roles of Sympathetic Activation and Insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Glycemic control in mice with targeted disruption of the glucagon receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Abnormal alpha cell function in human diabetes: the response to oral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

The essential role of glucagon in the pathogenesis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in prohormone convertase 2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

Evidence for a Major Role for Glucagon in Regulation of Plasma Glucose in Conscious, Nondiabetic, and Alloxan-Induced Diabetic Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00460.2004

10.1152/AJPENDO.00460.2004

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference